FDA approves experimental use of antiviral drug for Ebola, but still won’t allow testing with colloidal silver or Echinacea
by: L.J. Devon
NaturalNews.com
Tuesday, October 14, 2014
Right now, speculators are bubbling with anticipation, as drug company stocks are set to make impressive gains. Ever since Thomas Eric Duncan was quarantined at a Dallas hospital, it was only a matter of time before he would be subjected to new experimental drugs. Not long thereafter, the US FDA approved Chimerix’s new experimental drug brincidofovir, to be exclusively used on Duncan.
Isn’t it amazing how fast these new pharmacological brews are whipped up each time there is a hyped-up outbreak of some sort? The whole Ebola scenario almost appears contrived by drug companies and biotechnology experts, who seem to have the answer ready for the stock market as soon as the new pandemic breaks out.
Viruses often become resistant to drug company pharmacology
The Rest…HERE
